{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:14:57Z","timestamp":1793218497772,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015835","name":"Department of Health, Taipei City Government","doi-asserted-by":"publisher","award":["10901-62-069"],"award-info":[{"award-number":["10901-62-069"]}],"id":[{"id":"10.13039\/501100015835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015835","name":"Department of Health, Taipei City Government","doi-asserted-by":"publisher","award":["10901-62-069"],"award-info":[{"award-number":["10901-62-069"]}],"id":[{"id":"10.13039\/501100015835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015835","name":"Department of Health, Taipei City Government","doi-asserted-by":"publisher","award":["10901-62-069"],"award-info":[{"award-number":["10901-62-069"]}],"id":[{"id":"10.13039\/501100015835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015835","name":"Department of Health, Taipei City Government","doi-asserted-by":"publisher","award":["10901-62-069"],"award-info":[{"award-number":["10901-62-069"]}],"id":[{"id":"10.13039\/501100015835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015835","name":"Department of Health, Taipei City Government","doi-asserted-by":"publisher","award":["10901-62-069"],"award-info":[{"award-number":["10901-62-069"]}],"id":[{"id":"10.13039\/501100015835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015835","name":"Department of Health, Taipei City Government","doi-asserted-by":"publisher","award":["10901-62-069"],"award-info":[{"award-number":["10901-62-069"]}],"id":[{"id":"10.13039\/501100015835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015835","name":"Department of Health, Taipei City Government","doi-asserted-by":"publisher","award":["10901-62-069"],"award-info":[{"award-number":["10901-62-069"]}],"id":[{"id":"10.13039\/501100015835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cognitive impairment is a growing problem with increasing burden in global aging. Older adults with major depressive disorder (MDD) have higher risk of dementia. Neurofilament light chain (NfL) has been proven as a potential biomarker in neurodegenerative disease, including dementia. We aimed to investigate the association between cognitive deficits and NfL levels in older adults with MDD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this cross-sectional study, we enrolled 39 MDD patients and 15 individuals with mild neurocognitive disorder or major neurocognitive disorder, Alzheimer\u2019s type, as controls, from a tertiary psychiatric hospital. Both groups were over age 65 and with matched Mini-Mental State Examination (MMSE) score. Demographic data, clinical variables, and plasma NfL levels were obtained. We used cluster analysis according to their cognitive profile and estimated the correlation between plasma NfL levels and each cognitive domain.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the MDD group, participants had higher rate of family psychiatry history and current alcohol use habit compared with controls. Control group of neurocognitive disorders showed significantly lower score in total MMSE and higher plasma NfL levels. Part of the MDD patients presented cognitive deficits clustered with that of neurocognitive disorders (cluster A). In cluster A, the total MMSE score (<jats:italic>r<\/jats:italic>=-0.58277, <jats:italic>p<\/jats:italic>=0.0287) and the comprehension domain (<jats:italic>r<\/jats:italic>=-0.71717, <jats:italic>p<\/jats:italic>=0.0039) were negatively correlated to NfL levels after adjusting for age, while the associations had not been observed in the other cluster.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We noted the negative correlation between NfL levels and cognition in MDD patients clustered with neurodegenerative disorder, Alzheimer\u2019s type. NfL could be a promising candidate as a biomarker to predict subtype of patients in MDD to develop cognitive decline. Further longitudinal studies and within MDD cluster analysis are required to validate our findings for clinical implications.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-024-04960-z","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T07:03:56Z","timestamp":1713251036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cluster analysis dissecting cognitive deficits in older adults with major depressive disorder and the association with neurofilament light chain"],"prefix":"10.1186","volume":"24","author":[{"given":"Cynthia Yi-an","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chiang","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho-Yin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chih","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hsiu","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"issue":"2","key":"4960_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"Collaborators GBDDF","year":"2022","unstructured":"Collaborators GBDDF. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):105\u201325.","journal-title":"Lancet Public Health"},{"issue":"1","key":"4960_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"GBDD Collaborators","year":"2019","unstructured":"Collaborators GBDD. Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88\u2013106.","journal-title":"Lancet Neurol"},{"issue":"6","key":"4960_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrneurol.2011.60","volume":"7","author":"AL Byers","year":"2011","unstructured":"Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7(6):323\u201331.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"4960_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ana.20405","volume":"57","author":"G Dal Forno","year":"2005","unstructured":"Dal Forno G, et al. Depressive symptoms, sex, and risk for Alzheimer\u2019s disease. Ann Neurol. 2005;57(3):381\u20137.","journal-title":"Ann Neurol"},{"issue":"3","key":"4960_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0165-0327(02)00004-6","volume":"73","author":"LV Kessing","year":"2003","unstructured":"Kessing LV, Nilsson FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord. 2003;73(3):261\u20139.","journal-title":"J Affect Disord"},{"issue":"5","key":"4960_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","volume":"63","author":"RL Ownby","year":"2006","unstructured":"Ownby RL, et al. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006;63(5):530\u20138.","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"4960_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/JGP.0b013e31822001c1","volume":"20","author":"AL Byers","year":"2012","unstructured":"Byers AL, et al. Dysthymia and depression increase risk of dementia and mortality among older veterans. Am J Geriatr Psychiatry. 2012;20(8):664\u201372.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"9","key":"4960_CR8","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/JGP.0b013e31817e739a","volume":"16","author":"TJ Story","year":"2008","unstructured":"Story TJ, et al. Neurocognitive correlates of response to treatment in late-life depression. Am J Geriatr Psychiatry. 2008;16(9):752\u20139.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"10","key":"4960_CR9","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1017\/S0033291713002535","volume":"44","author":"PL Rock","year":"2014","unstructured":"Rock PL, et al. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44(10):2029\u201340.","journal-title":"Psychol Med"},{"issue":"6","key":"4960_CR10","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1017\/S0033291710001911","volume":"41","author":"HJ Conradi","year":"2011","unstructured":"Conradi HJ, Ormel J, de Jonge P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med. 2011;41(6):1165\u201374.","journal-title":"Psychol Med"},{"issue":"3","key":"4960_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1017\/S0033291700035662","volume":"26","author":"BC Beats","year":"1996","unstructured":"Beats BC, Sahakian BJ, Levy R. Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med. 1996;26(3):591\u2013603.","journal-title":"Psychol Med"},{"issue":"11","key":"4960_CR12","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1176\/appi.ajp.161.11.2081","volume":"161","author":"JT O'Brien","year":"2004","unstructured":"O\u2019Brien JT, et al. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry. 2004;161(11):2081\u201390.","journal-title":"Am J Psychiatry"},{"key":"4960_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1192\/bjp.186.3.197","volume":"186","author":"I Hickie","year":"2005","unstructured":"Hickie I, et al. Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression. Br J Psychiatry. 2005;186:197\u2013202.","journal-title":"Br J Psychiatry"},{"issue":"11","key":"4960_CR14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/JGP.0b013e318202clc6","volume":"19","author":"YC Yeh","year":"2011","unstructured":"Yeh YC, et al. Subtypes of mild cognitive impairment among the elderly with major depressive disorder in remission. Am J Geriatr Psychiatry. 2011;19(11):923\u201331.","journal-title":"Am J Geriatr Psychiatry"},{"key":"4960_CR15","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2147\/NDT.S114542","volume":"13","author":"R Strawbridge","year":"2017","unstructured":"Strawbridge R, Young AH, Cleare AJ. Biomarkers for depression: recent insights, current challenges and future prospects. Neuropsychiatr Dis Treat. 2017;13:1245\u201362.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"4960_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/mp.2016.120","volume":"22","author":"J Keller","year":"2017","unstructured":"Keller J, et al. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Mol Psychiatry. 2017;22(4):527\u201336.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"4960_CR17","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s00259-015-3291-3","volume":"43","author":"KY Wu","year":"2016","unstructured":"Wu KY, et al. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45\/Amyvid) PET study. Eur J Nucl Med Mol Imaging. 2016;43(6):1067\u201376.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"4960_CR18","doi-asserted-by":"publisher","first-page":"e01016","DOI":"10.1002\/brb3.1016","volume":"8","author":"KY Wu","year":"2018","unstructured":"Wu KY, et al. Diversity of neurodegenerative pathophysiology in nondemented patients with major depressive disorder: Evidence of cerebral amyloidosis and hippocampal atrophy. Brain Behav. 2018;8(7):e01016.","journal-title":"Brain Behav"},{"issue":"10","key":"4960_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14(10):577\u201389.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"4960_CR20","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3233\/JAD-210092","volume":"82","author":"N Darmanthe","year":"2021","unstructured":"Darmanthe N, et al. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer\u2019s Disease within 5 Years. J Alzheimers Dis. 2021;82(3):951\u201364.","journal-title":"J Alzheimers Dis"},{"key":"4960_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neurobiolaging.2021.07.013","volume":"107","author":"B Lim","year":"2021","unstructured":"Lim B, et al. CSF neurofilament light may predict progression from amnestic mild cognitive impairment to Alzheimer\u2019s disease dementia. Neurobiol Aging. 2021;107:78\u201385.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"4960_CR22","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3390\/biomedicines10051045","volume":"10","author":"K Dhiman","year":"2022","unstructured":"Dhiman K, et al. Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study. Biomedicines. 2022;10(5):1045.","journal-title":"Biomedicines"},{"issue":"9","key":"4960_CR23","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1532-5415.1992.tb01992.x","volume":"40","author":"TN Tombaugh","year":"1992","unstructured":"Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40(9):922\u201335.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"4960_CR24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.euroneuro.2005.04.003","volume":"15","author":"C Berr","year":"2005","unstructured":"Berr C, Wancata J, Ritchie K. Prevalence of dementia in the elderly in Europe. Eur Neuropsychopharmacol. 2005;15(4):463\u201371.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"4960_CR25","first-page":"79","volume":"84","author":"EL Cunningham","year":"2015","unstructured":"Cunningham EL, et al. Dementia. Ulster Med J. 2015;84(2):79\u201387.","journal-title":"Ulster Med J"},{"issue":"3","key":"4960_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res"},{"issue":"18","key":"4960_CR27","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1001\/jama.1993.03500180078038","volume":"269","author":"RM Crum","year":"1993","unstructured":"Crum RM, et al. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993;269(18):2386\u201391.","journal-title":"JAMA"},{"issue":"2","key":"4960_CR28","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jad.2013.04.028","volume":"150","author":"M Zimmerman","year":"2013","unstructured":"Zimmerman M, et al. Severity classification on the Hamilton Depression Rating Scale. J Affect Disord. 2013;150(2):384\u20138.","journal-title":"J Affect Disord"},{"key":"4960_CR29","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology, W. DDD Definition and general considerations. 2018-02-07 cited 2020; Available from: https:\/\/www.whocc.no\/atc_ddd_index\/."},{"issue":"4","key":"4960_CR30","first-page":"555","volume":"45","author":"R Albi\u0144ski","year":"2011","unstructured":"Albi\u0144ski R, Kleszczewska-Albi\u0144ska A, Bedy\u0144ska S. Geriatric Depression Scale (GDS). Validity and reliability of different versions of the scale--review. Psychiatr Pol. 2011;45(4):555\u201362.","journal-title":"Psychiatr Pol"},{"issue":"10","key":"4960_CR31","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/gps.1375","volume":"20","author":"LM Brown","year":"2005","unstructured":"Brown LM, Schinka JA. Development and initial validation of a 15-item informant version of the Geriatric Depression Scale. Int J Geriatr Psychiatry. 2005;20(10):911\u20138.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"4960_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000525615","volume":"51","author":"YC Wei","year":"2022","unstructured":"Wei YC, et al. Normative Data of Mini-Mental State Examination, Montreal Cognitive Assessment, and Alzheimer\u2019s Disease Assessment Scale-Cognitive Subscale of Community-Dwelling Older Adults in Taiwan. Dement Geriatr Cogn Disord. 2022;51(4):365\u201376.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"4960_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0377-0427(87)90125-7","volume":"20","author":"PJ Rousseeuw","year":"1987","unstructured":"Rousseeuw PJ. Silhouettes: A graphical aid to the interpretation and validation of cluster analysis. Journal of Computational and Applied Mathematics. 1987;20:53\u201365.","journal-title":"Journal of Computational and Applied Mathematics"},{"key":"4960_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jad.2019.08.049","volume":"259","author":"EA Carbone","year":"2019","unstructured":"Carbone EA, et al. Adverse childhood experiences and clinical severity in bipolar disorder and schizophrenia: A transdiagnostic two-step cluster analysis. J Affect Disord. 2019;259:104\u201311.","journal-title":"J Affect Disord"},{"issue":"4","key":"4960_CR35","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cger.2013.07.009","volume":"29","author":"NL Campbell","year":"2013","unstructured":"Campbell NL, et al. Risk factors for the progression of mild cognitive impairment to dementia. Clin Geriatr Med. 2013;29(4):873\u201393.","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"4960_CR36","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","volume":"12","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, et al. A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun. 2021;12(1):3400.","journal-title":"Nat Commun"},{"key":"4960_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jpsychires.2021.05.072","volume":"140","author":"F Bavato","year":"2021","unstructured":"Bavato F, et al. Altered neuroaxonal integrity in schizophrenia and major depressive disorder assessed with neurofilament light chain in serum. J Psychiatr Res. 2021;140:141\u20138.","journal-title":"J Psychiatr Res"},{"key":"4960_CR38","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jpsychires.2023.01.009","volume":"158","author":"MC Huang","year":"2023","unstructured":"Huang MC, et al. Comorbidity of ketamine dependence with major depressive disorder increases the vulnerability to neuroaxonal pathology. J Psychiatr Res. 2023;158:360\u20134.","journal-title":"J Psychiatr Res"},{"issue":"2","key":"4960_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/ijnp\/pyab068","volume":"25","author":"MH Chen","year":"2022","unstructured":"Chen MH, et al. Neurofilament Light Chain Is a Novel Biomarker for Major Depression and Related Executive Dysfunction. Int J Neuropsychopharmacol. 2022;25(2):99\u2013105.","journal-title":"Int J Neuropsychopharmacol"},{"key":"4960_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.genhosppsych.2020.01.006","volume":"64","author":"H Zhao","year":"2020","unstructured":"Zhao H, et al. Association of serum biomarker neurofilament light concentration with post-stroke depression: A preliminary study. Gen Hosp Psychiatry. 2020;64:17\u201325.","journal-title":"Gen Hosp Psychiatry"},{"issue":"4","key":"4960_CR41","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1007\/s10072-022-05914-2","volume":"43","author":"W Yin","year":"2022","unstructured":"Yin W, et al. Plasma neurofilament light chain levels are associated with depressive and anxiety symptoms in Parkinson\u2019s disease. Neurol Sci. 2022;43(4):2839\u201343.","journal-title":"Neurol Sci"},{"issue":"2","key":"4960_CR42","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.maturitas.2014.05.009","volume":"79","author":"S Bennett","year":"2014","unstructured":"Bennett S, Thomas AJ. Depression and dementia: cause, consequence or coincidence? Maturitas. 2014;79(2):184\u201390.","journal-title":"Maturitas"},{"issue":"10","key":"4960_CR43","first-page":"1003","volume":"112","author":"H Baba","year":"2010","unstructured":"Baba H. A consideration for the mechanism of the transition from depression to dementia. Seishin Shinkeigaku Zasshi. 2010;112(10):1003\u20138.","journal-title":"Seishin Shinkeigaku Zasshi"},{"issue":"1","key":"4960_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4088\/JCP.10m06766","volume":"73","author":"H Baba","year":"2012","unstructured":"Baba H, et al. Metabolism of amyloid-\u03b2 protein may be affected in depression. J Clin Psychiatry. 2012;73(1):115\u201320.","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"4960_CR45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11920-019-1047-7","volume":"21","author":"KS Bingham","year":"2019","unstructured":"Bingham KS, Flint AJ, Mulsant BH. Management of Late-Life Depression in the Context of Cognitive Impairment: a Review of the Recent Literature. Curr Psychiatry Rep. 2019;21(8):74.","journal-title":"Curr Psychiatry Rep"},{"issue":"4","key":"4960_CR46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/0891988704269823","volume":"17","author":"S Baudic","year":"2004","unstructured":"Baudic S, et al. Executive deficits in elderly patients with major unipolar depression. J Geriatr Psychiatry Neurol. 2004;17(4):195\u2013201.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"12","key":"4960_CR47","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1017\/S0033291707001134","volume":"37","author":"LL Herrmann","year":"2007","unstructured":"Herrmann LL, Goodwin GM, Ebmeier KP. The cognitive neuropsychology of depression in the elderly. Psychol Med. 2007;37(12):1693\u2013702.","journal-title":"Psychol Med"},{"key":"4960_CR48","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jad.2018.08.034","volume":"241","author":"JG Keilp","year":"2018","unstructured":"Keilp JG, et al. The lack of meaningful association between depression severity measures and neurocognitive performance. J Affect Disord. 2018;241:164\u201372.","journal-title":"J Affect Disord"},{"issue":"4","key":"4960_CR49","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1017\/S0033291709990833","volume":"40","author":"S K\u00f6hler","year":"2010","unstructured":"K\u00f6hler S, et al. The pattern and course of cognitive impairment in late-life depression. Psychol Med. 2010;40(4):591\u2013602.","journal-title":"Psychol Med"},{"issue":"6","key":"4960_CR50","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/archpsyc.61.6.587","volume":"61","author":"MA Butters","year":"2004","unstructured":"Butters MA, et al. The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry. 2004;61(6):587\u201395.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"4960_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0891988708328213","volume":"22","author":"DC Steffens","year":"2009","unstructured":"Steffens DC, McQuoid DR, Potter GG. Outcomes of older cognitively impaired individuals with current and past depression in the NCODE study. J Geriatr Psychiatry Neurol. 2009;22(1):52\u201361.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"3","key":"4960_CR52","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jagp.2012.12.009","volume":"21","author":"GG Potter","year":"2013","unstructured":"Potter GG, et al. Neuropsychological predictors of dementia in late-life major depressive disorder. Am J Geriatr Psychiatry. 2013;21(3):297\u2013306.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"4960_CR53","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.12740\/PP\/45368","volume":"50","author":"N Ciesielska","year":"2016","unstructured":"Ciesielska N, et al. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis Psychiatr Pol. 2016;50(5):1039\u201352.","journal-title":"Meta-analysis. Psychiatr Pol"},{"issue":"4","key":"4960_CR54","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1017\/S1041610218001370","volume":"31","author":"TCC Pinto","year":"2019","unstructured":"Pinto TCC, et al. Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer\u2019s Disease (AD) in the elderly? Int Psychogeriatr. 2019;31(4):491\u2013504.","journal-title":"Int Psychogeriatr"},{"issue":"5","key":"4960_CR55","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1017\/S1041610218001023","volume":"31","author":"R Van Patten","year":"2019","unstructured":"Van Patten R, Britton K, Tremont G. Comparing the Mini-Mental State Examination and the modified Mini-Mental State Examination in the detection of mild cognitive impairment in older adults. Int Psychogeriatr. 2019;31(5):693\u2013701.","journal-title":"Int Psychogeriatr"},{"key":"4960_CR56","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12877-015-0103-3","volume":"15","author":"PT Trzepacz","year":"2015","unstructured":"Trzepacz PT, et al. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults. BMC Geriatr. 2015;15:107.","journal-title":"BMC Geriatr"},{"issue":"2","key":"4960_CR57","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jad.2013.03.021","volume":"150","author":"L Grayson","year":"2013","unstructured":"Grayson L, Thomas A. A systematic review comparing clinical features in early age at onset and late age at onset late-life depression. J Affect Disord. 2013;150(2):161\u201370.","journal-title":"J Affect Disord"},{"issue":"1","key":"4960_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13607863.2012.717253","volume":"17","author":"N Sachs-Ericsson","year":"2013","unstructured":"Sachs-Ericsson N, et al. A longitudinal study of differences in late- and early-onset geriatric depression: depressive symptoms and psychosocial, cognitive, and neurological functioning. Aging Ment Health. 2013;17(1):1\u201311.","journal-title":"Aging Ment Health"},{"issue":"12","key":"4960_CR59","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.jagp.2014.02.006","volume":"22","author":"RS Mackin","year":"2014","unstructured":"Mackin RS, et al. Association of age at depression onset with cognitive functioning in individuals with late-life depression and executive dysfunction. Am J Geriatr Psychiatry. 2014;22(12):1633\u201341.","journal-title":"Am J Geriatr Psychiatry"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-04960-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-024-04960-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-024-04960-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T07:07:39Z","timestamp":1713251259000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-024-04960-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4960"],"URL":"https:\/\/doi.org\/10.1186\/s12877-024-04960-z","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,16]]},"assertion":[{"value":"30 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the participants have given written informed consent. The Research Ethics Committee of Taipei City Hospital approved our study (TCHIRB-10812017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}